[Dangerous increase in serum potassium following succinylcholine administration].
D000328:Adult; D001639:Bicarbonates / Q000627:therapeutic use; D002056:Burns / Q000188:drug therapy*; D002118:Calcium / Q000627:therapeutic use; D002675:Child, Preschool; D005260:Female; D005942:Gluconates / Q000627:therapeutic use; D006323:Heart Arrest / Q000139:chemically induced*; D006336:Heart Massage; D006801:Humans; D006947:Hyperkalemia / Q000139:chemically induced* / Q000517:prevention & control / Q000628:therapy; D008297:Male; D009422:Nervous System Diseases / Q000188:drug therapy*; D003473:Neuromuscular Nondepolarizing Agents / Q000627:therapeutic use; D010102:Oxygen Inhalation Therapy; D012151:Resuscitation; D012964:Sodium / Q000627:therapeutic use; D013390:Succinylcholine / Q000009:adverse effects* / Q000037:antagonists & inhibitors; D013742:Tetanus / Q000188:drug therapy*; D013997:Time Factors; D014947:Wounds and Injuries / Q000188:drug therapy*
D001639:Bicarbonates; D005942:Gluconates; D003473:Neuromuscular Nondepolarizing Agents; D012964:Sodium; D013390:Succinylcholine; D002118:Calcium
Gefährlicher Anstieg des Serumkaliums nach Succinylcholin.